2023
DOI: 10.1039/d3dt01648j
|View full text |Cite
|
Sign up to set email alerts
|

A novel chiral oxazoline copper(ii)-based complex inhibits ovarian cancer growthin vitroandin vivoby regulating VEGF/VEGFR2 downstream signaling pathways and apoptosis factors

Abstract: A novel chiral oxazoline copper (II)-based complex {[Cu(C13H14NO3S)2]}2 (Cu-A) was synthesized by in-situ reaction using L-Methioninol and 4-Hydroxyisophthalaldehyde, sodium hydroxide and copper (II) nitrate trihydrate as reactants. Its crystal structure...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 55 publications
0
5
0
Order By: Relevance
“…In addition, two chiral tetranucleate copper-based complexes were prepared into nanoparticles, and their stability under physiological conditions was observed by transmission electron microscopy, and their cellular uptake was investigated by ICP-MS. The results showed that these two copper-based complexes could stably enter MDA-MB-231 cells and HUVECs under physiological conditions. (b) Here, the uptake of HA-Cu, HA-Co, and HA-Ni by the MDA-MB-231 cells was analyzed using ICP-MS because of HA-Cu, HA-Co, and HA-Ni not having fluorescence properties and some limited conditions. After MDA-MB-231 cells were treated with HA-Cu (5.0 μM, 7.5 μM), HA-Co (30.0 μM, 60.0 μM), and HA-Ni (40 μM, 80.0 μM) for 6 h, respectively, the level of copper, cobalt, and nickel in the MDA-MB-231 cells was evaluated by ICP-MS. As shown in Figure A – C, the intracellular copper levels in cells treated with HA-Cu, cobalt levels in cells treated with HA-Co, and nickel levels in cells treated with HA-Ni were all elevated compared to the control group, exhibiting a positive correlation with the concentrations of HA-Cu, HA-Co, and HA-Ni, respectively.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…In addition, two chiral tetranucleate copper-based complexes were prepared into nanoparticles, and their stability under physiological conditions was observed by transmission electron microscopy, and their cellular uptake was investigated by ICP-MS. The results showed that these two copper-based complexes could stably enter MDA-MB-231 cells and HUVECs under physiological conditions. (b) Here, the uptake of HA-Cu, HA-Co, and HA-Ni by the MDA-MB-231 cells was analyzed using ICP-MS because of HA-Cu, HA-Co, and HA-Ni not having fluorescence properties and some limited conditions. After MDA-MB-231 cells were treated with HA-Cu (5.0 μM, 7.5 μM), HA-Co (30.0 μM, 60.0 μM), and HA-Ni (40 μM, 80.0 μM) for 6 h, respectively, the level of copper, cobalt, and nickel in the MDA-MB-231 cells was evaluated by ICP-MS. As shown in Figure A – C, the intracellular copper levels in cells treated with HA-Cu, cobalt levels in cells treated with HA-Co, and nickel levels in cells treated with HA-Ni were all elevated compared to the control group, exhibiting a positive correlation with the concentrations of HA-Cu, HA-Co, and HA-Ni, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…When VEGFA binds to VEGFR2 receptors, VEGFR2-mediated signaling pathways are activated, thus promoting the growth, proliferation, and migration of tumor vascular endothelial cells. It can be seen that the VEGF/VEGFR2 signaling pathway is closely related to the formation of new blood vessels in tumor. Erk1/2, AKT, FAK, and their phosphorylated proteins p-Erk1/2, p-AKT, and p-FAK downstream of the VEGF/VEGFR2 signal transduction pathway can regulate cell proliferation, survival, migration, and tumor angiogenesis. (b) The expression of VEGFR2 along with various other genes associated with angiogenesis is controlled by FAK, and VEGFR2 is positively correlated with FAK in breast cancer patients . FAK is a tyrosine kinase at the intersection of Erk1/2, PI3K/Akt, MAPK, and JAK/STAT signaling pathways.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations